Feedback
European Shorting
My Portfolios
Browse Gurus
Print
Email
From Baron Funds' fourth quarter letter.
Baron Funds Comments on Perrigo
Shares of Perrigo Co. (PRGO), the largest manufacturer of store brand, over-thecounter pharmaceutical products, fell after quarterly revenues in its Nutritionals segment, which includes private label infant formula and vitamins, fell short of expectations. We believe that the shortfall was explained by a combination of short term factors, and we are optimistic that the company's infant formula revenues are poised for strong growth, particularly in China, where its points of distribution are increasing.We are also encouraged by Perrigo's recent accretive acquisition of Sergeant's Pet Care, through which the company entered the market for private-label pet medications.
From Baron Funds' fourth quarter letter.
From Baron Funds' fourth quarter letter.
Subscribe RSS
RSS